Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus

Department of Medicine, School of Public Health and Hygiene, Johns Hopkins Medical Institutions, Baltimore, Maryland.

OBJECTIVES. The purpose of this study was to characterize the histologic and immunopathologic results of 37 endomyocardial biopsy samples from patients infected with human immunodeficiency virus type 1 (HIV-1) who were evaluated for unexplained global left ventricular dysfunction. BACKGROUND. Recent studies have identified a growing number of patients infected with HIV-1 who develop unexplained left ventricular dysfunction and congestive heart failure. Myocarditis has been confirmed at autopsy in small numbers of such patients, although a pathogenic opportunistic infectious agent can rarely be identified. METHODS. All patients had moderate to severe global left ventricular hypokinesia on two-dimensional echocardiography. Endomyocardial biopsy samples were evaluated by standard histologic studies, immunoperoxidase staining and in situ hybridization for cytomegalovirus and HIV-1 gene sequences. RESULTS. Twenty-eight patients presented with New York Heart Association functional class III or IV congestive heart failure. Four patients had myocarditis secondary to known etiologies (opportunistic infection n = 2; drug-induced hypersensitivity myocarditis n = 2). Of the remaining 33 samples, 17 (51%) showed histologic evidence of idiopathic active or borderline myocarditis. Immunohistologic findings revealed induced expression of major histocompatibility class I antigen on myocytes and increased numbers of infiltrating CD8+ T lymphocytes. Specific hybridization within myocytes was observed in 5 of 33 samples with the HIV-1 antisense riboprobe and in 16 of 33 samples with the cytomegalovirus immediate early (IE-2) antisense riboprobe. All but one patient with specific myocyte hybridization presented with congestive heart failure; all patients had myocarditis and CD4+ cell counts < 100/mm3. CONCLUSIONS. This study demonstrates that cardiotropic virus infection and myocarditis may be important in the pathogenesis of symptomatic HIV-associated cardiomyopathy.

This article has been cited by other articles:

				S. K. Grinspoon, C. Grunfeld, D. P. Kotler, J. S. Currier, J. D. Lundgren, M. P. Dube, S. E. Lipshultz, P. Y. Hsue, K. Squires, M. Schambelan, et al. State of the Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS: Executive Summary Circulation, July 8, 2008; 118(2): 198 - 210. [Full Text] [PDF]

				M. P. Dube, S. E. Lipshultz, C. J. Fichtenbaum, R. Greenberg, A. D. Schecter, S. D. Fisher, and for Working Group 3 Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature Circulation, July 8, 2008; 118(2): e36 - e40. [Full Text] [PDF]

				A. Karavidas, M. Foukarakis, G. Lazaros, M. Chini, I. Fotiadis, S. Arapi, T. Gialernios, N. Potamitis, P. Gargalianos, E. Matsakas, et al. Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients Int J STD AIDS, April 1, 2008; 19(4): 227 - 231. [Abstract] [Full Text] [PDF]

				M. Khaleduzzaman, J. Francis, M. E. Corbin, E. McIlwain, M. Boudreaux, M. Du, T. W. Morgan, and K. E. Peterson Infection of Cardiomyocytes and Induction of Left Ventricle Dysfunction by Neurovirulent Polytropic Murine Retrovirus J. Virol., November 15, 2007; 81(22): 12307 - 12315. [Abstract] [Full Text] [PDF]

				J. W. Magnani and G. W. Dec Myocarditis: Current Trends in Diagnosis and Treatment Circulation, February 14, 2006; 113(6): 876 - 890. [Full Text] [PDF]

				P. Y. Hsue and D. D. Waters What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection Circulation, December 20, 2005; 112(25): 3947 - 3957. [Abstract] [Full Text] [PDF]

				J.B. Sundstrom, D.E. Martinson, M. Mosunjac, P. Bostik, L.K. McMullan, R.M. Donahoe, M.B. Gravanis, and A.A. Ansari Norepinephrine Enhances Adhesion of HIV-1-Infected Leukocytes to Cardiac Microvascular Endothelial Cells Experimental Biology and Medicine, June 1, 2003; 228(6): 730 - 740. [Abstract] [Full Text] [PDF]

				K. Klingel, H.-C. Selinka, M. Sauter, C.-T. Bock, G. Szalay, and R. Kandolf Molecular mechanisms in enterovirus and parvovirus B19 associated myocarditis and inflammatory cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I8 - I12. [Abstract] [PDF]

				D. G. Kay, P. Yue, Z. Hanna, S. Jothy, E. Tremblay, and P. Jolicoeur Cardiac Disease in Transgenic Mice Expressing Human Immunodeficiency Virus-1 Nef in Cells of the Immune System Am. J. Pathol., July 1, 2002; 161(1): 321 - 335. [Abstract] [Full Text] [PDF]

				J.J. Monsuez, B. Gallet, L. Escaut, F. Vayre, J.C. Charniot, M. Pulik, M Merad, C. Minozzi, M. Slama, S. Weber, et al. Clinical outcome after coronary events in patients treated with HIV-protease inhibitors Eur. Heart J., December 2, 2000; 21(24): 2079 - 2080. [PDF]

				N. E. Bowles, D. L. Kearney, J. Ni, A. R. Perez-Atayde, M. W. Kline, J. T. Bricker, N. A. Ayres, S. E. Lipshultz, W. T. Shearer, and J. A. Towbin The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease J. Am. Coll. Cardiol., September 1, 1999; 34(3): 857 - 865. [Abstract] [Full Text] [PDF]

				G. Barbaro, G. Di Lorenzo, M. Soldini, G. Giancaspro, B. Grisorio, A. Pellicelli, and G. Barbarini Intensity of Myocardial Expression of Inducible Nitric Oxide Synthase Influences the Clinical Course of Human Immunodeficiency Virus-Associated Cardiomyopathy Circulation, August 31, 1999; 100(9): 933 - 939. [Abstract] [Full Text] [PDF]

				P. Chariot, H. Perchet, I. Monnet, S. Malnick, S. Goland, A. Flotats, P. Domingo, I. Carrio, G. Barbaro, G. Barbarini, et al. Dilated Cardiomyopathy in HIV-Infected Patients N. Engl. J. Med., March 4, 1999; 340(9): 732 - 735. [Full Text]

				G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, and The Gruppo Italiano per lo Studio Cardiologico dei Incidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive Patients N. Engl. J. Med., October 15, 1998; 339(16): 1093 - 1099. [Abstract] [Full Text] [PDF]

				S. E. Lipshultz Dilated Cardiomyopathy in HIV-Infected Patients N. Engl. J. Med., October 15, 1998; 339(16): 1153 - 1155. [Full Text]

				M. A. Rebolledo, P. Krogstad, F. Chen, K. M. Shannon, and T. S. Klitzner Infection of Human Fetal Cardiac Myocytes by a Human Immunodeficiency Virus-1–Derived Vector Circ. Res., October 5, 1998; 83(7): 738 - 742. [Abstract] [Full Text] [PDF]

				H. Hanawa, T. Inomata, Y. Okura, S. Hirono, Y. Ogawa, T. Izumi, M. Kodama, and Y. Aizawa T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis Circ. Res., July 27, 1998; 83(2): 133 - 140. [Abstract] [Full Text] [PDF]

				P F Currie, J H Goldman, A L P Caforio, A J Jacob, M K Baig, R P Brettle, A J Haven, N A Boon, and W J McKenna Cardiac autoimmunity in HIV related heart muscle disease Heart, June 1, 1998; 79(6): 599 - 604. [Abstract] [Full Text]

				S. E. Lipshultz, E. J. Orav, S. P. Sanders, and S. D. Colan Immunoglobulins and Left Ventricular Structure and Function in Pediatric HIV Infection Circulation, October 15, 1995; 92(8): 2220 - 2225. [Abstract] [Full Text]

				P. F Currie, A. J Jacob, A. R Foreman, R. A Elton, R. P Brettle, and N. A Boon Heart muscle disease related to HIV infection: prognostic implications BMJ, December 17, 1994; 309(6969): 1605 - 1607. [Abstract] [Full Text]